What is Balchem Corp. Annual Revenue?

Balchem Corp. Annual Revenue rose 3.39%, in the last year to $953.68 M. Its sector's average revenue growth for the last fiscal year was 0.86%.

What is Balchem Corp. Annual Net Profit?

Balchem Corp. Annual Net Profit rose 18.36% in the last year to $128.48 M. Its sector's average net profit growth for the last fiscal year was 7.84%.

What is Balchem Corp. Price to Earning Ratio?

Balchem Corp. Price to Earning Ratio is 41.84, higher than its sector PE ratio of 24.52.

What is Balchem Corp. Stock Price?

Balchem Corp. Stock Price rose 6.01% and outperformed its sector by 1.88% in the past year.

What is Balchem Corp. Quarterly Revenue?

Balchem Corp. Quarterly Revenue rose 4.94% YoY to $240 M. Its sector's average revenue growth YoY for the quarter was 0.22%.

What is Balchem Corp. Quarterly Net profit?

Balchem Corp. Quarterly Net profit rose 26.02% YoY to $33.58 M. Its sector's average net profit growth YoY for the quarter was 56.16%.

What is Balchem Corp. Debt to Equity Ratio?

Balchem Corp. Debt to Equity Ratio of 0.18 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Balchem Corp. Return on Equity(ROE)?

Balchem Corp. Return on Equity(ROE) for the last financial year was 11.66%, in the normal range of 10% to 20%.

What is Balchem Corp. Mutual Fund Holding?

Balchem Corp. Mutual Fund Holding increased by 0.36% in the last quarter to 70.33.

What is Balchem Corp. Promoter Share Holding?

Balchem Corp. Promoter Share Holding increased by 0.09% in the most recent quarter to 0.57%.

What is Balchem Corp. Interest Coverage Ratio?

Balchem Corp. Interest Coverage Ratio is 11.07, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Balchem Corp. Institutional Holding?

Balchem Corp. Institutional Holding decreased by 1.5% in the last quarter to 89.87.

How is the Balchem Corp. today?

The Balchem Corp. today is trading in the down by -0.33% at 165.24.

How has Balchem Corp. performed historically?

The Balchem Corp. is currently trading down -0.33% on an intraday basis in the past week the index fell -2.34%. The index has been down -4.79% in the past quarter and rose 6.01% in the past year. You can view this in the overview section.

Balchem Corp. XNAS: BCPC

Balchem Corp. Live Share Price Today, Share Analysis and Chart

Name: Balchem Corp.: Is Infosys Ltd. worth buying?
Item: Balchem Corp.
Rating: 2.45104175
Author: Trendlyne DVM scores

Expensive Performer

Download real time

165.24 -0.55 (-0.33%)

174.4K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Balchem Corp. Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	5,375.7
PE TTM High in industry Unavailable in chosen country	41.8
PEG TTM High in industry Unavailable in chosen country	2.3
Price to Book Below industry Median Unavailable in chosen country	4.7
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	89.9
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	4.9
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	3.4
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	26
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	18.4
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	19.8
Operating Profit Margin TTM % High in industry Unavailable in chosen country	19.2
Piotroski Score High in industry Unavailable in chosen country	7
Rel Perf vs Sector quarter% Unavailable in chosen country	-4.2
ROE Annual % Below industry Median Unavailable in chosen country	11.7
RoA Annual % High in industry Unavailable in chosen country	8.1

All financials are in USD Million and price data in USD

High Financial Strength

66.7 / 100

Expensive Valuation

17.5 / 100

Technically Neutral

45.3 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

199

1Yr Price target upside is 21%

3 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Neutral Zone

56.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Balchem Corp. Stock Price Analysis

Day Price Range -0.3% 1 Day return Unavailable in chosen country	165.2 (LTP) 162.8167 LowHigh
Week Price Range -2.3% 1 Week return Unavailable in chosen country	165.2 (LTP) 162.8170.7 LowHigh
Month Price Range -0.5% 1 Month return Unavailable in chosen country	165.2 (LTP) 154.8177.4 LowHigh
52 Week Price Range 6.0% 1 Year return Unavailable in chosen country	165.2 (LTP) 137.7186 LowHigh

View full Share Price History

Balchem Corp. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Balchem Corp.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

3.9

Avg. Estimate

4.7

Low Estimate

4.2

High Estimate

5.1

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 18.6% in FY25

Consensus Recommendation

2 ANALYST Recommendations

BUY

The consensus recommendation from 2 analysts for Balchem Corp. is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Balchem Corp. Stock Analysis

Balchem Corp. stock analysis with key metrics, changes, and trends.

Balchem Corp. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$953.68 M	3.39%	positive	Annual Revenue rose 3.39%, in the last year to $953.68 M. Its sector's average revenue growth for the last fiscal year was 0.86%.
Annual Net Profit	$128.48 M	18.36%	positive	Annual Net Profit rose 18.36% in the last year to $128.48 M. Its sector's average net profit growth for the last fiscal year was 7.84%.
Price to Earning Ratio	41.84	-	negative	Price to Earning Ratio is 41.84, higher than its sector PE ratio of 24.52.
Stock Price	$165.24	6.01%	positive	Stock Price rose 6.01% and outperformed its sector by 1.88% in the past year.
Quarterly Revenue	$240 M	4.94%	positive	Quarterly Revenue rose 4.94% YoY to $240 M. Its sector's average revenue growth YoY for the quarter was 0.22%.
Quarterly Net profit	$33.58 M	26.02%	positive	Quarterly Net profit rose 26.02% YoY to $33.58 M. Its sector's average net profit growth YoY for the quarter was 56.16%.
Debt to Equity Ratio	0.18	-	positive	Debt to Equity Ratio of 0.18 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	11.66 %	11.66%	neutral	Return on Equity(ROE) for the last financial year was 11.66%, in the normal range of 10% to 20%.
Mutual Fund Holding	70.33 %	0.36%	positive	Mutual Fund Holding increased by 0.36% in the last quarter to 70.33.
Promoter Share Holding	0.57 %	0.09%	positive	Promoter Share Holding increased by 0.09% in the most recent quarter to 0.57%.
Interest Coverage Ratio	11.07	-	positive	Interest Coverage Ratio is 11.07, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	89.87 %	-1.5%	negative	Institutional Holding decreased by 1.5% in the last quarter to 89.87.

VIEW LESS

Loading data..

Balchem Corp. - Company Profile

What does Balchem Corp. do?

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Gross Remuneration

2025

Gross Remuneration

Year

Balchem Corp. Live Share Price Today, Share Analysis and Chart

Balchem Corp. Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Balchem Corp. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Balchem Corp. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Balchem Corp.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 18.6% in FY25

Consensus Recommendation

The consensus recommendation from 2 analysts for Balchem Corp. is BUY

Balchem Corp. Stock Analysis

Balchem Corp. stock analysis with key metrics, changes, and trends.

Annual Revenue rose 3.39%, in the last year to $953.68 M. Its sector's average revenue growth for the last fiscal year was 0.86%.

Annual Net Profit rose 18.36% in the last year to $128.48 M. Its sector's average net profit growth for the last fiscal year was 7.84%.

Price to Earning Ratio is 41.84, higher than its sector PE ratio of 24.52.

Stock Price rose 6.01% and outperformed its sector by 1.88% in the past year.

Quarterly Revenue rose 4.94% YoY to $240 M. Its sector's average revenue growth YoY for the quarter was 0.22%.

Quarterly Net profit rose 26.02% YoY to $33.58 M. Its sector's average net profit growth YoY for the quarter was 56.16%.

Debt to Equity Ratio of 0.18 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 11.66%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 0.36% in the last quarter to 70.33.

Promoter Share Holding increased by 0.09% in the most recent quarter to 0.57%.

Interest Coverage Ratio is 11.07, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding decreased by 1.5% in the last quarter to 89.87.

Balchem Corp. - Company Profile

What does Balchem Corp. do?

Balchem Corp. Management structure

Mr. Theodore L. Harris

Chairman of the Board, President and Chief Executive Officer

Mr. William A. Backus

Vice President and Chief Accounting Officer

Mr. C. Martin Bengtsson

Executive Vice President and Chief Financial Officer

Mr. Job van L. Gunsteren

Senior Vice President and General Manager, Specialty Products

Ms. Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

Mr. Martin Luther Reid

Senior Vice President and Chief Supply Chain Officer

Balchem Corp. Board of directors

Mr. Theodore L. Harris

Chairman of the Board, President and Chief Executi